139 related articles for article (PubMed ID: 8589010)
1. Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II.
Pedersen-Bjergaard J
Ann Oncol; 1995 Oct; 6(8):751-3. PubMed ID: 8589010
[No Abstract] [Full Text] [Related]
2. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.
Ottone T; Hasan SK; Voso MT; Ledda A; Montefusco E; Fenu S; Pagoni M; Hubmann M; Lunghi M; Platzbecker U; Lo-Coco F
Am J Hematol; 2014 Mar; 89(3):346-7. PubMed ID: 24375429
[No Abstract] [Full Text] [Related]
4. DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D
N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534
[TBL] [Abstract][Full Text] [Related]
5. A case of therapy-related extramedullary acute promyelocytic leukemia.
Chen Z; Mostafavi HS; Shevrin DH; Morgan R; Vye MV; Stone JF; Sandberg AA
Cancer Genet Cytogenet; 1996 Jan; 86(1):29-30. PubMed ID: 8616781
[TBL] [Abstract][Full Text] [Related]
6. Insights into leukemogenesis from therapy-related leukemia.
Pedersen-Bjergaard J
N Engl J Med; 2005 Apr; 352(15):1591-4. PubMed ID: 15829541
[No Abstract] [Full Text] [Related]
7. Therapy-related acute promyelocytic leukemia following etoposide-based chemotherapy in non-seminomatous germ cell tumor.
Kumar TN; ; Gandhi LV; Raghunadharao D; Sadashivudu G
J Postgrad Med; 2014; 60(1):84-5. PubMed ID: 24625948
[TBL] [Abstract][Full Text] [Related]
8. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases.
Gillis S; Sofer O; Zelig O; Dann EJ; Lotan H; Ben Yehuda D; Isacson R; Rachmilewitz EA; Ben-Bassat I; Polliack A
Ann Oncol; 1995 Oct; 6(8):777-9. PubMed ID: 8589014
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II.
Pedersen-Bjergaard J
Leuk Res; 1992 Aug; 16(8):733-5. PubMed ID: 1326684
[No Abstract] [Full Text] [Related]
11. Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology.
Sinha S; Aish L; Oo TH
Am J Hematol; 2006 Jun; 81(6):475-6. PubMed ID: 16680741
[No Abstract] [Full Text] [Related]
12. Etoposide-related acute promyelocytic leukemia.
Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
14. Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor.
Inokura K; Onishi Y; Shimosegawa K; Okitsu Y; Katsuoka Y; Fujiwara T; Fukuhara N; Ishizawa K; Harigae H
Ann Hematol; 2012 Nov; 91(11):1825-6. PubMed ID: 22543830
[No Abstract] [Full Text] [Related]
15. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia with trisomy 8 and del(9)(q22) after treatment of cervical cancer with concurrent chemoradiotherapy: a case report.
Kim J; Park TS; Kim JS; Song J; Lee KA; Cho SY; Oh SH; Choi JR
Onkologie; 2011; 34(7):388-90. PubMed ID: 21734427
[No Abstract] [Full Text] [Related]
17. MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
Tsujioka T; Wada H; Yamamori S; Otsuki T; Suemori S; Kondo T; Nakanishi H; Suetsugu Y; Mikami M; Sugihara T
Int J Hematol; 2003 Dec; 78(5):439-42. PubMed ID: 14704037
[TBL] [Abstract][Full Text] [Related]
18. A case of acute promyelocytic leukemia during gefitinib treatment.
Ennishi D; Sezaki N; Senoo T; Terui Y; Hatake K; Hino N
Int J Hematol; 2006 Oct; 84(3):284-5. PubMed ID: 17020873
[No Abstract] [Full Text] [Related]
19. Acute promyelocytic leukaemia developing into acute myeloblastic leukaemia.
Atwater SK
Br J Haematol; 1993 Oct; 85(2):433. PubMed ID: 8280624
[No Abstract] [Full Text] [Related]
20. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.
Ratain MJ; Rowley JD
Ann Oncol; 1992 Feb; 3(2):107-11. PubMed ID: 1318741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
